Abstract
Mass spectrometric methods directed to screening libraries of compounds for agents that inhibit entry of Severe Acute Respiratory Syndrome (SARS) coronavirus (CoV) into cells are provided, along with methods for comparatively evaluating inhibitors of the SARS CoV.
Original language | American English |
---|---|
State | Published - Nov 16 2006 |
Keywords
- Mass spectrometry
- Patents
- SARS
- Severe acute respiratory syndrome
- US20060257861 A1
Disciplines
- Chemicals and Drugs
- Medical Toxicology
- Medicine and Health Sciences